ARTES offers a range of biosimilar producing cell lines and processes for out-licensing and technology transfer. The listed cell lines are based on yeast, E. coli or mammalian expression system.
| Interferon alpha2a | yeast; marketed in Mena region; new technology with improved yield; RCB, USP, DSP IPC/QC protocols available; PEGylated process available |
| Interferon alpha2b | yeast; licensed to India; RCB, USP, DSP IPC/QC protocols available; PEGylated process available |
| Hirudin | yeast; marketed in Mena region; new technology with improved yield available, MCB/WCB, USP, DSP, IPC/QC protocols available |
| Bivalirudin | yeast; licensed to Egypt; RCB, USP, DSP IPC/QC protocols available |
| Full length factor VIII | mammalian; MCB/WCB, USP, DSP IPC/QC protocols available |
| Insulin | yeast; cell line and process as marketed in India; RCB, USP, DSP IPC/QC protocols available |
| Detemir | yeast; RCB, USP protocols available; IPC/QC & DSP development time: approx. 6 months |
| Liraglutide | yeast; RCB, USP protocols available; IPC/QC & DSP development time: approx. 6 months |
| Lispro | yeast; proof-of-concept for expression achieved; cell line & process to be developed; development time: approx. 9 months |
| Glargin | yeast; proof-of-concept for expression achieved; cell line & process to be developed; development time: approx. 9 months |
| Teduglutide | yeast; cell line & process to be developed; development time: approx. 9 months |
| Aspart | yeast; cell line & process to be developed; development time: approx. 9 months |
| G-CSF | E. coli; RCB, USP protocols available; IPC/QC & DSP development time: approx. 6 months |
| hGrowth Hormone | yeast; RCB, USP protocols available, IPC/QC & DSP development time: approx. 6 months |
| PTH | yeast; MCB/WCB, USP; DSP IPC/QC protocols available |
| Follicle stimulating Hormone | mammalian; MCB/WCB, USP, DSP IPC/QC protocols available |
| Staphylokinase | yeast; RCB, USP, DSP IPC/QC protocols available |
| HSA | yeast; RCB, USP protocols available; IPC/QC & DSP development time: approx. 6 months |
To obtain a quote, please contact us at info(at)artes-biotechnology.com indicating name of the biosimilar process of interest to you. We will revert to you with a dedicated offer specifying delivery times and costs.